BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8882606)

  • 1. Characterization of the pharmacological profile of the potent LTB4 antagonist CP-105,696 on murine LTB4 receptors in vitro.
    Showell HJ; Breslow R; Conklyn MJ; Hingorani GP; Koch K
    Br J Pharmacol; 1996 Mar; 117(6):1127-32. PubMed ID: 8882606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
    Showell HJ; Conklyn MJ; Alpert R; Hingorani GP; Wright KF; Smith MA; Stam E; Salter ED; Scampoli DN; Meltzer S; Reiter LA; Koch K; Piscopio AD; Cortina SR; Lopez-Anaya A; Pettipher ER; Milici AJ; Griffiths RJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):946-54. PubMed ID: 9618393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
    Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
    Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
    Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
    Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.
    Turner CR; Breslow R; Conklyn MJ; Andresen CJ; Patterson DK; Lopez-Anaya A; Owens B; Lee P; Watson JW; Showell HJ
    J Clin Invest; 1996 Jan; 97(2):381-7. PubMed ID: 8567958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN).
    Jackson RH; Morrissey MM; Sills MA; Jarvis MF
    J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of the leukotriene B4 receptor antagonist CP-105,696 in man following single oral administration.
    Liston TE; Conklyn MJ; Houser J; Wilner KD; Johnson A; Apseloff G; Whitacre C; Showell HJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):115-21. PubMed ID: 9491823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity.
    Sarau HM; Foley JJ; Schmidt DB; Martin LD; Webb EF; Tzimas MN; Breton JJ; Chabot-Fletcher M; Underwood DC; Hay DW; Kingsbury WD; Chambers PA; Pendrak I; Jakas DR; Sathe GM; Van Horn S; Daines RA; Griswold DE
    Prostaglandins Leukot Essent Fatty Acids; 1999 Jul; 61(1):55-64. PubMed ID: 10477044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice.
    Aiello RJ; Bourassa PA; Lindsey S; Weng W; Freeman A; Showell HJ
    Arterioscler Thromb Vasc Biol; 2002 Mar; 22(3):443-9. PubMed ID: 11884288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene B4 receptors on guinea pig alveolar eosinophils.
    Maghni K; de Brum-Fernandes AJ; Földes-Filep E; Gaudry M; Borgeat P; Sirois P
    J Pharmacol Exp Ther; 1991 Sep; 258(3):784-9. PubMed ID: 1653838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site.
    Cheng JB; Cheng EI; Kohi F; Townley RG
    J Pharmacol Exp Ther; 1986 Jan; 236(1):126-32. PubMed ID: 3001280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (E)-3-[[[[6-(2-carboxyethenyl)-5-[[8-(4- methoxyphenyl)octyl]oxy]-2-pyridinyl]-methyl]thio]methyl]benzoic acid and related compounds: high affinity leukotriene B4 receptor antagonists.
    Daines RA; Chambers PA; Eggleston DS; Foley JJ; Griswold DE; Haltiwanger RC; Jakas DR; Kingsbury WD; Martin LD; Pendrak I
    J Med Chem; 1994 Sep; 37(20):3327-36. PubMed ID: 7932560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
    Sehmi R; Rossi AG; Kay AB; Cromwell O
    Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of leukotriene B4 and its analogs to human polymorphonuclear leukocyte membrane receptors.
    Bomalaski JS; Mong S
    Prostaglandins; 1987 Jun; 33(6):855-67. PubMed ID: 2823316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of protein kinase C redistribution and inhibition of leukotriene B4-induced inositol 1,4,5-trisphosphate generation in human neutrophils by lipoxin A4.
    Chung-a-on KO; Soyombo O; Spur BW; Lee TH
    Br J Pharmacol; 1996 Mar; 117(6):1334-40. PubMed ID: 8882633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.